Related Experiment Video
Updated: Jul 17, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Clinical Outcomes of Children With COVID-19 by SARS-CoV-2 Strain: A Cohort Study
Lauren M Klingensmith1, Swati Goel1, Vinay N Kampalath2
1From the Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA.
Insights
The Delta variant of SARS-CoV-2 did not significantly alter disease severity in children compared to earlier strains. Children aged 1-4 years and those with public insurance were more likely to be hospitalized.
Area of Science:
- Pediatric infectious diseases
- Virology
- Public health
Background:
- The emergence of SARS-CoV-2 variants, such as Delta, necessitated an understanding of their impact on pediatric disease severity.
- Previous studies have not fully elucidated the comparative outcomes of SARS-CoV-2 Delta variant infections in children.
Purpose of the Study:
- To compare disease outcomes and identify predictors of severe outcomes in children infected with the SARS-CoV-2 Delta variant versus pre-Delta strains.
- To assess the influence of comorbidities on hospitalization rates in pediatric Delta variant infections.
Main Methods:
- Retrospective cohort study conducted at a single urban academic children's hospital emergency department.
- Inclusion criteria: children aged 0-18 years with a positive SARS-CoV-2 test.
- Primary outcomes: hospital admission and COVID-directed therapies.
Main Results:
- A trend towards decreased hospital admission was observed in the Delta variant cohort, though not statistically significant (OR, 0.79; 95% CI, 0.51-1.23).
- Predictors of hospital admission included age 1-4 years (OR, 2.35; 95% CI, 1.23-4.57) and public insurance (OR, 1.80; 95% CI, 1.08-3.01).
- Comorbidities increased odds of admission within the Delta cohort (OR, 2.52; 95% CI, 1.09-6.04), while Black children had lower odds of admission than white children.
Conclusions:
- Disease severity outcomes were similar between pediatric patients infected with SARS-CoV-2 pre-Delta and Delta variants, even in those with comorbidities.
- Continued research is crucial to monitor disease severity and risks in children, particularly with ongoing SARS-CoV-2 mutations like Omicron subvariants.
Objective:
We sought to investigate the disease outcomes and predictors of severe outcomes among children infected with the Delta variant of SARS-CoV-2 compared with pre-Delta strains.
Methods:
Single-center retrospective cohort study in an emergency department located within an urban academic children's hospital. Patients included children (0-18 years) who tested positive for SARS-CoV-2. Main outcomes measured include need for hospital admission or COVID-directed therapies.
Results:
There was a trend toward decreased hospital admission and no significant difference in the severity of outcomes in the Delta cohort relative to the pre-Delta cohort. The Delta cohort had lower odds of hospital admission (odds ratio [OR], 0.79; 95% confidence interval [CI], 0.51-1.23), but the result was not statistically significant. Logistic regression analyses showed that overall, age 1 to 4 years (OR, 2.35; 95% CI, 1.23-4.57) and public insurance (OR, 1.80, 95% CI, 1.08-3.01) were predictors of hospital admission. Within the Delta cohort, the presence of any comorbidity increased the odds of admission (OR, 2.52; 95% CI, 1.09-6.04). Black children had lower odds of admission than white children (overall OR, 0.53; 95% CI, 0.31-0.90; pre-Delta OR, 0.50; 95% CI, 0.26-0.95).
Conclusions:
The severity of measured disease outcomes was similar in pediatric patients when comparing children infected with the pre-Delta and Delta variants of SARS-CoV-2, even among children with comorbidities once adjusting for acuity.Ongoing research is essential to determine disease severity and risk for children with comorbidities because SARS-CoV-2 continues to mutate, including with Omicron subvariants.
More Related Videos
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Bias in Epidemiological Studies
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pneumonia III: Complications and Assessment
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Single Nucleotide Polymorphisms-SNPs

